Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19302753 | 0.85 | KDM4E (0.55) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL13593519 | 0.83 | LMNA (0.63) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL31115060 | 0.81 | MAOB (0.48) | CYP1A2 | |
| SCHEMBL31115092 | 0.81 | MAOB (0.48) | — | |
| SCHEMBL873209 | 0.80 | ALDH1A1 (0.48) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL2728660 | 0.80 | ALDH1A1 (0.51) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL25446084 | 0.79 | LMNA (0.42) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL21396062 | 0.79 | LMNA (0.49) | LMNAALDH1A1HSD17B10RECQL | |
| Acetic Acid SCHEMBL9528247 | 0.79 | ALDH1A1 (0.55) | LMNAALDH1A1MEN1CYP1A2CYP3A4 | |
| Rac-3-N-Butylphthalide SCHEMBL28830050 | 0.77 | MAOB (0.48) | LMNAALDH1A1MEN1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578049-B2 | Benzoic acid compound and method for preparing the same | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2023-02-14 | — | — | US | disclosed |
| EP-3845524-A1 | BENZOIC ACID COMPOUNDS AND PREPARATION METHOD THEREFORE AND APPLICATIONS THEREOF | Henan Genuine Biotech Co., Ltd. (CN) | 2021-07-07 | — | — | EP | disclosed |
| US-20210002244-A1 | BENZOIC ACID COMPOUND AND METHOD FOR PREPARING THE SAME | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2021-01-07 | — | — | US | disclosed |
| WO-2019179346-A1 | BENZOIC ACID COMPOUNDS AND PREPARATION METHOD THEREFORE AND APPLICATIONS THEREOF | 河南真实生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578049-B2 | Benzoic acid compound and method for preparing the same | GABBR2, GABRA1, GABRA6 | LMNA 493/4885ALDH1A1 1354/4885MEN1 320/4885 |
| US-20210002244-A1 | BENZOIC ACID COMPOUND AND METHOD FOR PREPARING THE SAME | GABBR2, GABRA1, GABRA6 | LMNA 493/4885ALDH1A1 1354/4885MEN1 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.